Showing results (141-150 of 220) with videos related to
Sort By:
Pageof 22
JCO Precision Oncology|September 21, 2020
Mutation Rates in Cancer Susceptibility Genes in Patients With Breast Cancer With Multiple Primary CancersKara N Maxwell, Brandon M Wenz, Abha Kulkarni, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|April 10, 2015
PMS2 monoallelic mutation carriers: the known unknownMcKinsey L Goodenberger, Brittany C Thomas, Douglas Riegert-Johnson, et al.Journal of the National Comprehensive Cancer Network : JNCCN|February 7, 2016
Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015Mary B Daly, Robert Pilarski, Jennifer E Axilbund, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2012
Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriersBrian S Finkelman, Wendy S Rubinstein, Sue Friedman, et al.Journal of the National Cancer Institute|May 20, 2020
Contribution of Germline Predisposition Gene Mutations to Breast Cancer Risk in African American WomenJulie R Palmer, Eric C Polley, Chunling Hu, et al.Journal of the National Comprehensive Cancer Network : JNCCN|April 8, 2020
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020Mary B Daly, Robert Pilarski, Matthew B Yurgelun, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 11, 2024
Development of a Breast Cancer Risk Prediction Model Integrating Monogenic, Polygenic, and Epidemiologic RiskSarah S Kalia, Nicholas J Boddicker, Siddhartha Yadav, et al.Journal of the National Comprehensive Cancer Network : JNCCN|January 6, 2021
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in OncologyMary B Daly, Tuya Pal, Michael P Berry, et al.JAMA Oncology|August 4, 2017
Baseline Surveillance in Li-Fraumeni Syndrome Using Whole-Body Magnetic Resonance Imaging: A Meta-analysisMandy L Ballinger, Ana Best, Phuong L Mai, et al.NPJ Breast Cancer|September 23, 2020
Association of germline variation with the survival of women with <i>BRCA1/2</i> pathogenic variants and breast cancerTaru A Muranen, Sofia Khan, Rainer Fagerholm, et al.Pageof 22